Zobrazeno 1 - 10
of 31
pro vyhledávání: '"O. V Aleinikova"'
Autor:
M. Yu. Goroshkova, Yu. V. Rumyantseva, O. V. Aleinikova, S. A. Dudkin, L. G. Fechina, A. V. Shamardina, O. V. Streneva, K. L. Kondratchik, L. M. Minkina, E. S. Lapotentova, E. V. Inyushkina, O. B. Kozlova, E. V. Zhukovskaya, O. P. Khlebnikova, E. V. Basharova, V. N. Timofeeva, G. P. Pavlova, V. D. Zlobina, O. A. Utrobina, E. S. Banshchikova, K. S. Aslanyan, E. V. Kondakova, E. V. Tselousova, N. V. Myakova, T. V. Turobova, O. V. Ryskal, O. Yu. Fuks, V. V. Lebedev, N. F. Chipsanova, S. R. Varfolomeeva, A. I. Karachunsky
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 25-33 (2022)
The paper presents the results of a multicenter randomized study of two-dose COLI-ASP regimens in therapy of consolidation of standard risk-group (SRG) children and adolescents with acute lymphoblastic leukemia (ALL) treated by the ALL-MB-2002 protoc
Externí odkaz:
https://doaj.org/article/273ffc5c215a492e9db3020d5e11e678
Autor:
J. V. Roumiantseva, A. I. Karachunsky, O. V. Aleinikova, L. G. Fechina, A. V. Schamardina, D. V. Litvinov, N. I. Ponomareva, E. G. Boichenko, L. V. Sidorenko, S. A. Dudkin, O. V. Streneva, K. L. Kondratchik, E. G. Mansurova, L. M. Minkina, E. S. Lapotentova, E. V. Inuschkina, N. B. Yudina, G. P. Pavlova, E. V. Zhukovskaya, O. P. Chlebnikova, S. N. Lagoiko, E. V. Bascharova, R. E. Denisov, V. D. Zlobina, E. S. Banschikova, K. S. Aslanyan, E. V. Kondakova, E. V. Celousova, N. V. Myakova, T. V. Turobova, O. V. Riskal, N. F. Chipsanova, S. R. Varfolomeeva, A. G. Rumiantsev
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 37-49 (2022)
Проанализирована значимость прогностических факторов эффективности терапии у детей с острым лимфобластным лейкозом (ОЛЛ), получающих
Externí odkaz:
https://doaj.org/article/60da326014b14be09d19043fc252c8e4
Publikováno v:
Онкогематология, Vol 0, Iss 2, Pp 17-21 (2022)
220 children with acute lymphoblastic leukemia (ALL) treated according to ALL-MB-2002 protocol are included in the study. Minimal residual disease (MRD) estimated in bone marrow by three-color flow cytometry on day 15 (n=99), day 36 (n=107) and befor
Externí odkaz:
https://doaj.org/article/968ef9da812d4371a1b38871f5ddfe40
Autor:
N. P. Kirsanova, O. V. Aleinikova, A. M. Kustanovich, T. V. Savitskay, R. I. Yutskevich, E. V. Volochnik, L. V. Baidun, Yu. E. Mareiko, Yu. S. Strongin, N. V. Minakovskay, N. V. Migal, I. V. Proleskovskay, I. V. Emelyanova, O. V. Karas, A. G. Drekov, M. M. Maschan, D. V. Litvinov, N. V. Myakova, E. V. Skorobogatova, D. D. Baidildina, I. I. Kalinina, G. G. Solopova, E. V. Suntsova, U. N. Petrova, L. A. Hachatryan, M. M. Scheider, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 5-13 (2022)
Protocol AML-MM-2000 treatment results of unfavorable prognostic group in children with primary acute myeloid leukemia (AML) in Russia and Belarus are presented. 105 children at the age from 2 weeks till 18 years (a median age — 10.8 years) are inc
Externí odkaz:
https://doaj.org/article/b5947a60a3844a338c3bdb12bb102b9d
Autor:
L. V. Guk, T. V. Savitskaya, D. A. Domninsky, V. O. Bobrinina, M. M. Schneider, A. A. Maschan, O. V. Aleinikova
Publikováno v:
Онкогематология, Vol 0, Iss 4, Pp 27-32 (2022)
Prognosis of patients with acute myeloid leukemia receiving intensive chemotherapy is defined as kariotyping anomalies, and mutations of genes responsible for surviving and self-maintenance leukemic cells. In the giving work incidence of mutation inv
Externí odkaz:
https://doaj.org/article/38efe043a43a4d2aa46c334aadeaad03
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 28-34 (2022)
Comparative pharmacoeconomic analysis of treatment according to ALL-MB-2002 protocol between two groups of children with acute lymphoblastic leukemia (ALL) (n=53) depending on use of intravenous immunoglobulin (IVIG) aiming to infectious complication
Externí odkaz:
https://doaj.org/article/5ba688ca515f405ab13fa11c2b2627aa
Autor:
S. P. Lukashyk, O. V. Aleinikova, V. M. Tsyrkunov, I. A. Karpov, Y. I. Isaykina, O. V. Krasko
Publikováno v:
Архивъ внутренней медицины, Vol 11, Iss 2, Pp 132-145 (2021)
Introduction. Liver cirrhosis (LC) is the final stage in the progression of chronic diffuse diseases. As common, late stages of LC do not respond to conservative treatment methods, so liver transplantation is the most effective method at this stage.
Externí odkaz:
https://doaj.org/article/8b7ce5cfc2e04fd6bc507895287572b2
Publikováno v:
Онкогематология, Vol 13, Iss 4, Pp 8-16 (2019)
Objective of the study . Analysis of the treatment outcomes of patients with MLL rearrangements in the Republic of Belarus within protocols AML-MM-2000 and AML-MM-2006.Materials and methods . The study included 151 patients with newly diagnosed acute
Externí odkaz:
https://doaj.org/article/683dc87c0d87414a8d3d8c9cca4311a8
Publikováno v:
Naukovyi Visnyk Natsionalnoho Hirnychoho Universytetu. :154-159
Purpose. To develop a mathematical approach to quantitative assessment of the effectiveness of digital marketing of territories. To determine the tasks of digital marketing of territories and directions for increasing its effectiveness. Methodology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::571a86ddf7f42baa205c50efecd302f4
https://doi.org/10.33271/nvngu/2023-1/154
https://doi.org/10.33271/nvngu/2023-1/154
Publikováno v:
Архивъ внутренней медицины, Vol 8, Iss 2, Pp 150-160 (2018)
Introduction. The importance of the HCV-infection is determined by the wide spread, progressive course, the formation of liver cirrhosis (LC) and hepatocellular carcinoma. The mechanisms of the effect of the virus on hepatic cells, the processes of f
Externí odkaz:
https://doaj.org/article/52a8e6fc75fa4b7cb16660866f9be3b0